Can a cancer drug slow ALS? a trial aims to find out
Disease control
Completed
This study tests whether bosutinib, a drug currently used for certain cancers, can help people with amyotrophic lateral sclerosis (ALS), a progressive nerve disease. The trial has two parts: the first finds a safe dose, and the second checks if that dose slows the decline in dail…
Phase: PHASE1, PHASE2 • Sponsor: Kyoto University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC